Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genprex (GNPX) Shares Issued (2016 - 2025)

Genprex (GNPX) has 9 years of Shares Issued data on record, last reported at $2.9 million in Q3 2025.

  • For Q3 2025, Shares Issued rose 5208.93% year-over-year to $2.9 million; the TTM value through Sep 2025 reached $12.0 million, up 74.7%, while the annual FY2024 figure was $12.0 million, 13.39% up from the prior year.
  • Shares Issued reached $2.9 million in Q3 2025 per GNPX's latest filing, up from $1.7 million in the prior quarter.
  • Across five years, Shares Issued topped out at $25.3 million in Q1 2021 and bottomed at $4.0 in Q4 2023.
  • Average Shares Issued over 5 years is $3.4 million, with a median of $764781.0 recorded in 2021.
  • Peak YoY movement for Shares Issued: crashed 99.91% in 2023, then surged 32150250.0% in 2024.
  • A 5-year view of Shares Issued shows it stood at $243548.0 in 2021, then crashed by 98.08% to $4672.0 in 2022, then plummeted by 99.91% to $4.0 in 2023, then soared by 32150250.0% to $1.3 million in 2024, then soared by 128.9% to $2.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $2.9 million in Q3 2025, $1.7 million in Q2 2025, and $6.0 million in Q1 2025.